Champion Healthcare Technologies , a SaaS provider that enables hospitals to manage surgical implants throughout their life cycle – from receipt, inventory storage, and usage, to post-surgical tracking and reporting — received investment from The Riverside Company, a global private equity firm. Through the investment, Champion is combining with HemaTerra Technologies (HemaTerra), a provider of SaaS-based solutions for independent and hospital-based blood collection centers and plasma collection centers. Riverside made an investment in HemaTerra earlier this year.
“We are thrilled to partner with The Riverside Company and to combine with HemaTerra,” says Champion’s Co-founder Peter Casady. “We look forward to continuing to make an impact on implant management through improved patient safety and hospital cost savings.”
Champion’s industry-leading solutions are used by many of the largest and most sophisticated health systems in the U.S. Through deep integration with vendors, system-wide visibility into implants, and robust analytics, Champion’s implant management software helps customers improve patient safety, reduce costs, and maintain compliance. The combined company will serve over 500 hospitals and many of the leading independent blood and plasma collection centers in the U.S.
“The combination of our companies will not only enable us to accelerate our growth in the hospital market but also to better serve our customers through new and innovative product development and expanded service offerings,” says Champion’s President, Maria Siambekos.
Champion chose to partner with Riverside, given its strong track record and commitment to investing in software and healthcare companies. To date, the firm has completed more than 150 investments in these areas and has a team of global experts dedicated to growing companies in these specializations.
“By combining with Champion, who share our approach of providing top-notch healthcare specialty software, we look forward to optimizing the healthcare supply chain. We are in a unique and exciting position to connect key supply chain stakeholders, including blood banks, tissue banks, hospitals, manufacturers, donors, and volunteers,” says HemaTerra CEO Todd Collins.
About The Riverside Company
The Riverside Company is a global private equity firm focused on investing in growing businesses valued at up to $400 million. Since its founding in 1988, Riverside has made more than 600 investments. The firm’s international private equity and structured capital portfolios include more than 90 companies.
About HemaTerra Technologies
HemaTerra provides industry-leading software that integrates to provide blood, plasma, and hospital organizations with a broad view of their supply chain for complete operations management. The suite of products assists customers with hospital order entry, donor recruitment, mobile drives, collections staffing, product QC, and equipment maintenance. Integration removes the barriers of information across departments so that customers can seamlessly run their entire operations.
About Champion Healthcare Technologies
Founded in 2005, Champion provides comprehensive implant management solutions to over 500 hospitals and health systems. Its broad portfolio enables organizations to effectively track and manage implants throughout their life cycle (i.e., receipt to explant) to improve patient safety, reduce costs, and minimize risk. Through deep integration with vendors, system-wide visibility into implants, and robust analytics, Champion empowers organizations to drive meaningful results.